Orchestra BioMed Holdings Cash Flow Statement (2021-2026) | OBIO

Cash Flow Statement Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income (Quarter)
-0.12M-0.12M-5.36M-7.89M-10.45M-10.09M-11.90M-16.96M-22.02M-12.48M-15.80M-25.19M-17.62M-16.10M-19.38M-21.57M-20.54M6.39M-24.75M-25.29M
Depreciation and Depletion (Quarter)
0.05M0.05M0.05M0.07M0.07M0.07M0.07M0.07M0.07M0.07M0.08M0.08M
Share-based Compensation (Quarter)
0.07M0.08M2.09M0.86M1.49M0.13M1.59M0.92M2.59M0.14M10.70M-0.31M2.96M8.30M0.36M0.47M11.00M9.90M
Gains from Investment Securities (Quarter)
0.14M1.01M-0.04M0.23M0.29M
Cash from Operations (Quarter)
-0.13M-0.03M-5.32M-7.96M-7.26M-8.74M-14.38M-10.49M-10.28M-10.97M-13.11M-10.21M-13.70M-13.54M-16.62M-15.53M-14.55M-2.27M-22.17M-19.33M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)
1.06M1.06M1.06M0.64M0.59M0.33M0.36M0.23M0.11M0.05M0.33M0.32M0.08M0.40M
Amortization of Deferred Charges (Quarter)
0.13M0.14M-0.14M0.44M0.15M0.16M0.16M-0.36M0.05M0.17M0.28M0.15M0.15M0.15M0.15M-0.23M0.06M0.17M
Depreciation & Amortization (CF) (Quarter)
0.05M0.05M0.05M0.07M0.07M0.07M0.07M0.07M0.07M0.07M0.08M0.08M0.08M0.08M0.08M0.08M0.09M0.10M
Change in Working Capital
Change in Receivables (Quarter)
-0.04M0.00M0.02M-0.02M0.10M-0.09M0.01M-0.03M0.01M0.04M-0.04M-0.00M-0.01M-0.03M0.04M-0.01M-0.03M
Change in Inventory (Quarter)
-0.04M0.10M0.20M-0.05M-0.04M-0.05M-0.04M0.01M-0.03M-0.04M0.16M-0.06M-0.04M0.05M0.18M-0.06M-0.03M-0.03M
Change in Account Payables (Quarter)
-0.02M-267.000.10M0.07M0.11M0.10M
Change in Accured Expenses (Quarter)
0.08M0.03M0.20M0.47M1.62M1.06M-1.79M0.78M0.67M0.49M-1.28M3.73M1.23M-0.71M-0.20M1.09M3.41M0.57M-3.06M-0.25M
Other Working Capital Changes (Quarter)
-0.07M0.56M-0.01M-0.04M1.50M-0.77M-0.27M0.32M0.06M-0.11M0.59M0.53M-0.04M-0.11M-0.14M-0.59M0.48M-0.49M
Investing Activities
Capital Expenditures (Quarter)
0.05M0.27M0.22M0.05M0.04M0.03M0.02M-0.00M0.01M0.11M0.07M0.11M0.11M0.03M-0.06M0.09M0.18M0.25M
Change in Acquisitions & Divestments (Quarter)
51.49M37.11M29.61M29.18M10.61M17.23M16.01M16.39M9.51M7.95M4.74M19.90M
Cash from Investing Activities (Quarter)
-0.05M-0.47M-0.22M-63.38M-43.53M8.12M12.95M33.15M5.86M10.42M0.56M-3.75M13.00M16.36M-38.58M-17.71M10.32M-23.31M
Financing Activities
Other financing activities (Quarter)
0.07M0.01M0.04M0.00M0.02M56.79M0.02M0.17M0.05M0.09M0.03M0.01M
Cash from Financing Activities (Quarter)
24.76M86.08M-2.50M-5.09M56.82M0.09M0.00M-10.70M0.02M0.17M15.04M13.95M-0.30M-0.43M76.40M12.66M5.53M34.75M
Additional items
Change in Cash (Quarter)
-0.13M-0.03M19.39M77.64M-9.98M-77.21M-1.09M-2.29M2.67M11.48M-7.24M0.39M1.89M-3.34M-3.91M0.40M23.26M-7.32M-6.32M-7.89M
Free Cash Flow (Quarter)
-0.13M-0.03M-5.37M-8.23M-7.48M-8.80M-14.42M-10.52M-10.30M-10.97M-13.12M-10.31M-13.77M-13.64M-16.73M-15.56M-14.49M-2.36M-22.35M-19.59M
Net Cash Flow (Quarter)
-0.13M-0.03M19.39M77.64M-9.98M-77.21M-1.09M-2.29M2.67M11.48M-7.24M0.39M1.89M-3.34M-3.91M0.40M23.26M-7.32M-6.32M-7.89M